SNORD114-7: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Target Name: SNORD114-7

NCBI ID: G767583

SNORD114-7

Other Name(s): Small nucleolar RNA, C/D box 114-7 | small nucleolar RNA, C/D box 114-7 | 14q(II-7)

SNORD114-7: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Small nucleolar RNA (snRNA) is a non-coding RNA molecule that plays a critical role in the regulation of gene expression in eukaryotic cells. One of the key functions of snRNA is to interact with small nucleolar RNA (snoRNA) processing modification system, which is responsible for modifying the stability and localization of snRNAs. C/D box 114-7 is a specific snRNA that is expressed in various tissues and cells and has been shown to play important roles in regulating gene expression.

The C/D box 114-7 is a small RNA molecule that is expressed in various tissues and cells. It is characterized by a conserved core structure that consists of a 19-nt stem-loop and a 30-nt C/D loop. The C/D loop is the region of the snRNA that interacts with the small nucleolar RNA (snoRNA) processing machinery, which is responsible for modifying the stability and localization of snRNAs.

Studies have shown that C/D box 114-7 is involved in a variety of cellular processes, including cell growth, apoptosis, and transcriptional regulation. For example, studies have shown that overexpression of C/D box 114-7 can lead to increased cell proliferation and enhanced cancer cell transformation. Additionally, C/D box 114-7 has been shown to play important roles in regulating cell apoptosis, which is a critical process that helps maintain tissue homeostasis and contributes to the development and progression of diseases.

Furthermore, C/D box 114-7 has also been shown to be involved in transcriptional regulation. Studies have shown that C/D box 114-7 can interact with various DNA-binding proteins and that this interaction can modulate gene expression. For example , studies have shown that C/D box 114-7 can interact with the transcription factor p360 and that this interaction can modulate the expression of genes involved in cell adhesion, migration and invasion.

Given the critical role that C/D box 114-7 plays in various cellular processes, it is a promising target for drug development. Studies have shown that various small molecules, including small molecules that mimic the activity of p360, have the potential to inhibit the activity of C/D box 114-7 and inhibit its ability to interact with DNA-binding proteins. Therefore, C/D box 114-7 may be a promising drug target for the treatment of various diseases.

In addition to its potential as a drug target, C/D box 114-7 is also a potential biomarker. Studies have shown that the expression of C/D box 114-7 is regulated by various factors, including DNA damage, cellular stress and hormonal changes. Therefore, the level of C/D box 114-7 expression can be used as a biomarker for a variety of diseases, including cancer, neurodegenerative diseases and cardiovascular diseases.

In conclusion, C/D box 114-7 is a small RNA molecule that is expressed in various tissues and cells and plays a critical role in the regulation of gene expression in eukaryotic cells. The C/D loop is the region of the snRNA that interacts with the small nucleolar RNA (snoRNA) processing machinery and is involved in a variety of cellular processes, including cell growth, apoptosis and transcriptional regulation. As a result, C/D box 114-7 is a promising target for drug development and a potential biomarker for the treatment of various diseases.

Protein Name: Small Nucleolar RNA, C/D Box 114-7

The "SNORD114-7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD114-7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets